Skip to main content

Javier Hernandez Losa

Institutions of which they are part

Predoctoral researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Javier Hernandez Losa

Institutions of which they are part

Predoctoral researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Red Temática de Investigación Cooperativa en Cáncer (RTICC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Angel García Jiménez, Roso Marès Pagès, Teresa Moline Marimon, Josep Castellví Vives, Pere Barba Suñol, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Stefania Landolfi , Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 209700
Reference: RD12/0036/0057
Duration: 01/01/2013 - 30/06/2017

Validación de Aprataxina como biomarcador de respuesta a Irinotecan en pacientes con cáncer colorrectal (ERANET- TRANSCAN)

IP: Diego Arango Corro
Collaborators: Javier Hernandez Losa, Stefania Landolfi , Elena Andretta
Funding agency: Instituto de Salud Carlos III
Funding: 135883
Reference: PI12/03103 (TRANSCAN)
Duration: 01/01/2013 - 30/06/2017

Identificación de nuevas dianas para el tratamiento del cáncer basada en el estudio de factores cap-independientes activados en tumores malignos

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Vicente Peg Camara, Trond Aasen
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 9283
Reference: FMM-2011-11
Duration: 01/09/2011 - 31/08/2012

Estudio de factores moleculares y vías de señalización asociados a resistencia/sensibilidad al tratamiento con Irvalec

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Javier Hernandez Losa
Funding agency: CENTRO PARA EL DESARROLLO TÉCNICO INDUSTRIAL (CDTI
Funding: 356298.75
Reference: CENIT-2009-01
Duration: 15/09/2009 - 31/12/2012

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición

Related professionals

Juliana Esperalba Esquerra

Juliana Esperalba Esquerra

Research technician
Microbiology
Read more
Sarai Garriga Edo

Sarai Garriga Edo

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Francesc Vallribera Valls

Francesc Vallribera Valls

General Surgery
Read more
Rodrigo De Almeida Toledo

Rodrigo De Almeida Toledo

Senior researcher
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.